Bone Biologics Corp. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending September 30, 2022 was 95.78% (a -0.73% decrease compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -100.13%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 110.49% (a -272.13% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was -64.19% (a 29.26% increase from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was -49.66% (a 67.32% increase from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending September 30, 2022 was -17199.69% (a -29.09% decrease compared to previous quarter)
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22
-17199.69% -24256.9% -30049.7%
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of Bone Biologics Corp.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof BBLG including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Bone Biologics Corp.

Bone Biologics Corp. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 95.78% 96.48% 357.9%
2021 -73118.41% 7824.14% 85.85% 110.49%
2020 -46.19% -64.19%
2019 -49.66%
2018 -29.68%
2017 -56.63%
2016 130.59%

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices